1 May 2020 – Crisis is the mother of invention and COVID-19 is no exception. But amid all the gloom are signs of a nascent revolution in how we create and develop new drugs, vaccines and diagnostics. The U.K. life sciences industry is rising to the challenge with a mix of collaboration, speed, creativity and resource commitment, to capitalize on the science and technology it has invested in over the last few years.
https://www.alchemab.com/wp-content/uploads/2020/03/Alchemab-logo.png00resiliencehttps://www.alchemab.com/wp-content/uploads/2020/03/Alchemab-logo.pngresilience2020-05-01 09:00:112020-11-26 10:26:17How the U.K. healthcare sector is leveraging its strengths to beat COVID-19
East Side, Office 1.02
London N1C 4AX
Meditrina Building 260
Babraham Research Campus